NCT02014558 2024-12-03Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid LeukemiaAstellas Pharma IncPhase 1/2 Completed265 enrolled 80 charts